ClassID:

20065

A61K9/1271 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Sub-classes:
Recent Application in this class:
#1
20260151507
2026-06-04

COMPOSITIONS AND METHODS FOR GENOME EDITING

#2
20260151337
2026-06-04

HYBRID BIOLOGICAL MEMBRANES, METHODS OF MAKING AND USES THEREOF

#3
20260144861
2026-05-28

COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION

#4
20260144810
2026-05-28

mRNA COMPOSITION FOR TREATING CANCER, PREPARATION CONTAINING THE SAME AND USE THEREOF

#5
20260144803
2026-05-28

LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF

#6
20260144752
2026-05-28

Multilamellar Vesicles and Methods and Uses Thereof

#7
20260144751
2026-05-28

LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF

#8
20260139063
2026-05-21

PRE-MEDICATION AND IMPROVED TREATMENT REGIMEN

#9
20260130856
2026-05-14

LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF

#10
20260130855
2026-05-14

GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#11
20260130852
2026-05-14

BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY

#12
20260125339
2026-05-07

IONIZABLE CATIONIC LIPIDS

#13
20260124224
2026-05-07

USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS

#14
20260124139
2026-05-07

LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL

#15
20260115221
2026-04-30

SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS

#16
20260115138
2026-04-30

LIPID NANOPARTICLES

#17
20260108627
2026-04-23

COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR CARDIOVASCULAR DISEASE

#18
20260108534
2026-04-23

LIPOSOMAL FORMULATIONS OF BCL INHIBITORS

#19
20260103715
2026-04-16

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

#20
20260102345
2026-04-16

POLYOXYALKYLENE-1,2-DIMYRISTOYL-GLYCEROL COMPOUNDS, WHEREIN THE POLYOXYALKYLENE IS A POLY(ETHYLENE OXIDE) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS

#21
20260091104
2026-04-02

NUCLEIC ACID VACCINES

#22
20260083860
2026-03-26

COMPOSITIONS AND METHODS FOR GENOME EDITING

#23
20260083674
2026-03-26

OXAZOLIDINONE LIPOSOME COMPOSITIONS

#24
20260078082
2026-03-19

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

#25
20260069714
2026-03-12

LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES

#26
20260069632
2026-03-12

Compositions for Drug Delivery and Methods of Use Thereof

#27
20260069540
2026-03-12

GENE DELIVERY AGENTS

#28
20260069535
2026-03-12

NEBULIZER KITS AND USES THEREOF

#29
20260060927
2026-03-05

LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF

#30
20260060926
2026-03-05

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

#31
20260053927
2026-02-26

LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES

#32
20260053857
2026-02-26

Compositions for Drug Delivery and Methods of Use Thereof

#33
20260053807
2026-02-26

ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF

#34
20260053806
2026-02-26

GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

#35
20260053754
2026-02-26

KAEMPFEROL BIOMIMETIC NANO-MATERIAL, METHOD FOR PREPARING SAME AND USE THEREOF

#36
20260053745
2026-02-26

METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES

#37
20260053744
2026-02-26

NANODELIVERY SYSTEMS FOR EXTENDED RELEASE OF ANTIBODIES

#38
20260048142
2026-02-19

METAL-CHELATED POLYPHENOL COMPLEX NANOPARTICLE, DRUG-LIPID PARTICLE, PREPARATION METHODS FOR THE SAME, AND USES THEREOF

#39
20260048054
2026-02-19

ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

#40
20260048010
2026-02-19

Synthetic Nanostructures Including Nucleic Acids and/or Other Entities

#41
20260041636
2026-02-12

LIPID FUSION DEPOT COMPOSITION WITH CONTROLLED INITIAL RELEASE, AND METHOD FOR PREPARING SAME

#42
20260027200
2026-01-29

Poxvirus mRNA Vaccine and Use

#43
20260027053
2026-01-29

POLYNUCLEOTIDE ENCAPSULATION AND PRESERVATION USING SELF-ASSEMBLING MEMBRANES

#44
20260021131
2026-01-22

USE OF MITOXANTRONE LIPOSOME IN COMBINATION WITH CAPECITABINE IN TREATING NASOPHARYNGEAL CARCINOMA

#45
20260015376
2026-01-15

CONTINUOUS FLOW METHODS FOR PRODUCING MANNOSE-1-PHOSPHATE, POLYMORPHS OF MANNOSE-1-PHOSPHATE, AND COMPOSITIONS AND USES RELATED THERETO

#46
20260014079
2026-01-15

CAROTENOID COMPOSITIONS AND USES THEREOF

#47
20260014078
2026-01-15

COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES

#48
20260014077
2026-01-15

NOVEL METHODS TO ENHANCE GENE DELIVERY

#49
20260014076
2026-01-15

SURFACE PEGYLATED SOLID LIPID NANOCARRIER DUALLY LOADED WITH ATAZANAVIR AND ELVITEGRAVIR FOR COMBINATION ANTIRETROVIRAL THERAPY

#50
20260014075
2026-01-15

IONIZABLE LIPID CONTAINING BIODEGRADABLE ESTER BOND AND LIPID NANOPARTICLES COMPRISING SAME

#51
20260007600
2026-01-08

NUCLEIC ACID DRUG FOR TREATING HYPERURICEMIA-RELATED DISEASES, PREPARATION METHOD THEREFOR, AND USE THEREOF

#52
20260002155
2026-01-01

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

#53
20260001838
2026-01-01

NANOMATERIALS

#54
20260000666
2026-01-01

Methods For Treating Pancreatic Cancer Using Combination Therapies

#55
20260000608
2026-01-01

COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS

#56
20250387332
2025-12-25

LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT

#57
20250387331
2025-12-25

PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT

#58
20250381300
2025-12-18

AAV PIGGYBAC TRANSPOSON POLYNUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREFOR

#59
20250381191
2025-12-18

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

#60
20250381153
2025-12-18

CURCUMIN COMPOUND COMPOSITION

#61
20250381139
2025-12-18

MULTI-TAIL TYPE IONIZABLE LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF

#62
20250375378
2025-12-11

mRNA LIPID NANOPARTICLES FOR THE TREATMENT OF NIEMANN-PICK TYPE C DISEASE

#63
20250367134
2025-12-04

PERIPHERALIZATION OF CENTRALLY-ACTING CANNABINOID-1 RECEPTOR ANTAGONISTS BY NANOPARTICLES FOR THE TREATMENT METABOLIC RELATED CONDITIONS

#64
20250360083
2025-11-27

LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF

#65
20250353931
2025-11-20

MULTI-SPECIFIC REAGENT FOR TARGETED DELIVERY OF LIPID NANOPARTICLES

#66
20250352541
2025-11-20

THERAPEUTIC FOR CANCER REFRACTORY TO IMMUNE CHECKPOINT INHIBITOR

#67
20250352472
2025-11-20

LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF

#68
20250346925
2025-11-13

FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE

#69
20250345277
2025-11-13

Ionizable Liposome, Preparation Thereof, and Application Thereof in Gene Delivery

#70
20250339393
2025-11-06

USE OF TRANSMEMBRANE PH GRADIENT LIPOSOMES FOR TREATING HYPERAMMONEMIC CRISIS ASSOCIATED WITH INBORN ERRORS OF METABOLISM

#71
20250333733
2025-10-30

NOVEL TARGETS AGAINST OVARIAN CANCER

#72
20250333396
2025-10-30

INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)

#73
20250332244
2025-10-30

IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA

#74
20250332187
2025-10-30

NOVEL RNA CONSTRUCT AND METHODS OF USE THEREOF FOR ENHANCING THE THERAPEUTIC EFFECTS OF CYTOTOXIC CELLS AND STEM CELLS

#75
20250332102
2025-10-30

ON-DEMAND RELEASE OF ANTIBIOTIC COMPOSITION AND METHOD FOR TREATING INFECTIONS

#76
20250326806
2025-10-23

Compositions of Phosphorylated Tau Peptides and Uses Thereof

#77
20250325702
2025-10-23

COMPOSITIONS AND METHODS FOR EDITING A TRANSTHYRETIN GENE

#78
20250325480
2025-10-23

Lipid Nanoparticle Compositions and Methods For Formulating Insoluble Drugs

#79
20250319188
2025-10-16

ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#80
20250319025
2025-10-16

COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF

#81
20250319024
2025-10-16

TARGETED NANOPARTICLES AND THEIR USES RELATED TO INFECTIOUS DISEASE

#82
20250313531
2025-10-09

Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof

#83
20250312277
2025-10-09

PEGYLATED LIPOSOMES AND USES THEREOF

#84
20250295587
2025-09-25

COMPLEX LIPID NANOPARTICLES ENCAPSULATING POLYPEPTIDES AND USES THEREOF

#85
20250281556
2025-09-11

PRODUCTION OF RNA POLYNUCLEOTIDES ENCODING PICORNAVIRUS

#86
20250281421
2025-09-11

COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF

#87
20250276091
2025-09-04

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

#88
20250275920
2025-09-04

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

#89
20250275919
2025-09-04

NANOTUBE-VESICLE COMPOSITIONS AND USES THEREOF

#90
20250275918
2025-09-04

LIPID COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

#91
20250268827
2025-08-28

COMBINED MEDICINAL DRUG INCLUDING LIPOSOME COMPOSITION ENCOMPASSING TOPOTECAN OR SALT THEREOF AND DNA DAMAGE REPAIR INHIBITOR

#92
20250268826
2025-08-28

IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF

#93
20250262155
2025-08-21

LITHE LIPOSOMES COMPRISING ABSORPTION ENHANCERS FOR ORAL DRUG DELIVERY

#94
20250257090
2025-08-14

Ribonucleic Acids With 4'-Thio-Modified Nucleotides and Related Methods

#95
20250255813
2025-08-14

TRIPTOLIDE LIGNOCERATE, LIPOSOME THEREOF AND PREPARATION METHOD THEREFOR

#96
20250242059
2025-07-31

CORONAVIRUS VACCINE

#97
20250242056
2025-07-31

METHODS AND COMPOSITIONS FOR USING PLASMA CELL DEPLETING AGENTS AND/OR B CELL DEPLETING AGENTS TO SUPPRESS HOST ANTI-AAV ANTIBODY RESPONSE AND ENABLE AAV TRANSDUCTION AND RE-DOSING

#98
20250241864
2025-07-31

NANOALUM PARTICLES CONTAINING A PEGYLATED LIPID SIZING AGENT

#99
20250241857
2025-07-31

PEGYLATED LIPOSOMES AND METHODS OF USE

#100
20250235483
2025-07-24

CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY

#101
20250235404
2025-07-24

PEG-LIPIDS AND LIPID NANOPARTICLES

#102
20250235403
2025-07-24

COMPOSITIONS AND METHODS OF THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS

#103
20250222001
2025-07-10

GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

#104
20250221936
2025-07-10

ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF

#105
20250221930
2025-07-10

A COMPOSITION COMPRISING LIPID NANOPARTICLES AND AN ANTIFUNGAL POLYENE

#106
20250214953
2025-07-03

SULFIDE-CONTAINING IONIZABLE LIPID AND LIPID NANOPARTICLE INCLUDING THE SAME

#107
20250213680
2025-07-03

LIPID NANOPARTICLE COMPOSITION COMPRISING GALLIC ACID DERIVATIVE LIPID AND USE THEREOF

#108
20250213664
2025-07-03

MRNAS ENCODING CHECKPOINT CANCER VACCINES AND USES THEREOF

#109
20250213578
2025-07-03

ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF

#110
20250213576
2025-07-03

ALPHA POLYGLUTAMATED PRALATREXATE AND USES THEREOF

#111
20250213476
2025-07-03

GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF

#112
20250213475
2025-07-03

LIPOSOMAL COMPOSITIONS

#113
20250205384
2025-06-26

HEMOSTATIC MATERIAL

#114
20250205362
2025-06-26

LIPID NANOPARTICLES

#115
20250197864
2025-06-19

LNCRNA TRANSCRIPTS IN MELANOMAGENESIS

#116
20250195686
2025-06-19

D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#117
20250195638
2025-06-19

TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES

#118
20250195621
2025-06-19

SYNTHETIC PLATELETS

#119
20250195432
2025-06-19

METHODS FOR PREPARING AND CHARACTERIZING ZEIN-FUCOIDAN CONJUGATED NANO-LIPOSOME FOR PHYTOL ENCAPSULATION

#120
20250195429
2025-06-19

LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS, AND METHOD FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS USING SAME

#121
20250188191
2025-06-12

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

#122
20250186345
2025-06-12

PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE

#123
20250177432
2025-06-05

RNA MOLECULES AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY

#124
20250177304
2025-06-05

TARGETED LIPOSOMAL GEMCITABINE AND METHODS THEREOF

#125
20250177303
2025-06-05

A DRUG NANOCARRIER SYSTEM TO DELIVER A COMBINATION OF TLR AGONISTS AND/OR A LIPOXIN PLUS IMMUNOGENIC CELL DEATH INDUCING CHEMOTHERAPEUTIC AGENTS FOR CANCER IMMUNOTHERAPY

#126
20250177302
2025-06-05

LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION

#127
20250177301
2025-06-05

TRIPLEX NANOPARTICLES

#128
20250170244
2025-05-29

COLLOIDAL PARTICLES FOR USE IN MEDICINE

#129
20250170062
2025-05-29

NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

#130
20250162977
2025-05-22

IONIZABLE CATIONIC LIPIDS

#131
20250161940
2025-05-22

LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS

#132
20250161455
2025-05-22

ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#133
20250161221
2025-05-22

Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle

#134
20250152735
2025-05-15

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

#135
20250152655
2025-05-15

EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA

#136
20250152578
2025-05-15

Stabilizing Camptothecin Pharmaceutical Compositions

#137
20250152513
2025-05-15

METHOD FOR PREPARING LIPOSOMES

#138
20250152511
2025-05-15

PLATINUM COMPLEXES AND USES THEREOF

#139
20250152510
2025-05-15

LIPIDS AND LIPID NANOPARTICLE FORMULATIONS

#140
20250145577
2025-05-08

STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS

#141
20250144212
2025-05-08

LIPOSOMES CONTAINING PHOSPHORYLATED TAU PEPTIDES FOR INDUCING SUSTAINED IMMUNE RESPONSES

#142
20250144028
2025-05-08

LIPIDS AND LIPID NANOPARTICLE FORMULATIONS

#143
20250144027
2025-05-08

METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY

#144
20250144026
2025-05-08

LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF

#145
20250136953
2025-05-01

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#146
20250135010
2025-05-01

CONCATEMERIC PEPTIDE EPITOPE RNAS

#147
20250134986
2025-05-01

STABILIZED LIPID NANOPARTICLE MRNA COMPOSITIONS AND USES THEREOF

#148
20250127920
2025-04-24

GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#149
20250127882
2025-04-24

NUCLEIC ACID-LIPID NANOPARTICLE AND METHOD USING THE SAME

#150
20250127720
2025-04-24

IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY

#151
20250120914
2025-04-17

LIPID NANOPARTICLES

#152
20250108128
2025-04-03

CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS

#153
20250108126
2025-04-03

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

#154
20250108007
2025-04-03

LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION

#155
20250099608
2025-03-27

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#156
20250099589
2025-03-27

ULTRASOUND-RESPONSIVE LIPOSOME NANOPARTICLES AND PREPARATION METHOD AND USE THEREOF

#157
20250099575
2025-03-27

MRNA VACCINE

#158
20250099574
2025-03-27

CORONAVIRUS VACCINE

#159
20250099393
2025-03-27

IONIZABLE LIPIDS, LIPID NANOPARTICLES, AND USES THEREOF

#160
20250099383
2025-03-27

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS

#161
20250090462
2025-03-20

LIPID COMPOUND AND PREPARATION METHOD THEREFOR, AND USE THEREOF

#162
20250090461
2025-03-20

CELL-WALL BINDING PROTEIN SPECIFICALLY TARGETING CUTIBACTERIUM ACNES

#163
20250090460
2025-03-20

Neurosome/Astrosome Compositions and Methods of Use

#164
20250082639
2025-03-13

ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

#165
20250082576
2025-03-13

CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF

#166
20250082575
2025-03-13

GAMMA POLYGLUTAMATED PRALATREXATE AND USES THEREOF

#167
20250074962
2025-03-06

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

#168
20250073164
2025-03-06

IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM

#169
20250066468
2025-02-27

LIPOSOME ENCAPSULATED AFFINITY DRUG

#170
20250064740
2025-02-27

MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO

#171
20250064739
2025-02-27

OXAZOLIDINONE LIPOSOME COMPOSITIONS

#172
20250064738
2025-02-27

MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A

#173
20250064736
2025-02-27

GAMMA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

#174
20250057776
2025-02-20

EXOSOME, METHOD OF FORMING SAME, AND COMPOSITION CONTAINING SAME

#175
20250057768
2025-02-20

LIPID-BASED COATING COMPOSITION, AND AN OBJECT HAVING A LIPID-BASED COATING

#176
20250057767
2025-02-20

COMPOSITION COMPRISING HYBRID EXOSOME

#177
20250057766
2025-02-20

LIPIDS FOR DRUG DELIVERY, NANOPARTICLES COMPRISING SAME, AND COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES

#178
20250049915
2025-02-13

NANOPARTICULATE FORMULATION

#179
20250049712
2025-02-13

HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER

#180
20250049711
2025-02-13

COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF

#181
20250041407
2025-02-06

VARICELLA ZOSTER VIRUS (VZV) VACCINE

#182
20250041393
2025-02-06

POLYNUCLEOTIDES ENCODING INTEGRIN BETA-6 AND METHODS OF USE THEREOF

#183
20250041390
2025-02-06

COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE

#184
20250041321
2025-02-06

SYSTEMS FOR TREATING PULMONARY INFECTIONS

#185
20250025505
2025-01-23

CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6 EXPRESSING CANCER

#186
20250018062
2025-01-16

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

#187
20250018055
2025-01-16

ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#188
20250017945
2025-01-16

LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF

#189
20250017867
2025-01-16

POLYNUCLEOTIDES ENCODING RELAXIN FOR THE TREATMENT OF FIBROSIS AND/OR CARDIOVASCULAR DISEASE

#190
20250017856
2025-01-16

CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS

#191
20250009858
2025-01-09

Peptide Conjugated Particles

#192
20250009679
2025-01-09

CATIONIC LIPID-BASED NANOCARRIER AND PREPARATION METHOD AND APPLICATION THEREOF

#193
20250009661
2025-01-09

PLASMA COATING METHOD OF NANOVESICLE SURFACE AND PLASMA JET DEVICE FOR PLASMA COATING OF NANOVESICLE SURFACE

#194
20250009660
2025-01-09

LIPID COMPOUND, LIPOSOME, EXOSOME, LIPID NANOPARTICLE, AND DRUG DELIVERY SYSTEM

#195
20250009659
2025-01-09

DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS

#196
20250000796
2025-01-02

Stabilizing Camptothecin Pharmaceutical Compositions

#197
20240425495
2024-12-26

OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF

#198
20240425494
2024-12-26

OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF

#199
20240425442
2024-12-26

IONIZABLE CATIONIC LIPIDS

#200
20240424007
2024-12-26

REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES

#201
20240417738
2024-12-19

IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER

#202
20240409597
2024-12-12

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

#203
20240408214
2024-12-12

NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA

#204
20240408191
2024-12-12

NUCLEIC ACID VACCINES

#205
20240408020
2024-12-12

Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle

#206
20240408012
2024-12-12

LIPOSOMAL COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE

#207
20240399100
2024-12-05

INTRAARTICULAR POSTEROMEDIAL LANDMARK INJECTION FOR LOWER EXTREMITY ANALGESIA

#208
20240398931
2024-12-05

NUCLEIC ACID VACCINES

#209
20240398927
2024-12-05

NUCLEIC ACID VACCINES

#210
20240390524
2024-11-28

RNA CONSTRUCTS AND USES THEREOF

#211
20240390514
2024-11-28

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#212
20240390484
2024-11-28

RNA FORMULATIONS AND LIPIDS

#213
20240390480
2024-11-28

Nucleic acid vaccines

#214
20240390283
2024-11-28

LIPOSOMAL COMPOSITIONS AND USES OF SAME

#215
20240390282
2024-11-28

DRUG-LOADED LIPOSOMES AND USES THEREOF IN TREATING BIOFILM

#216
20240390281
2024-11-28

LIPOCOACERVATES AND METHODS OF MAKING AND USING SAME

#217
20240383841
2024-11-21

IONIZABLE CATIONIC LIPIDS

#218
20240382581
2024-11-21

PAN-HUMAN CORONAVIRUS VACCINES

#219
20240382424
2024-11-21

LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF

#220
20240374734
2024-11-14

Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate

#221
20240374520
2024-11-14

PROTEOLIPID VESICLES FORMULATED WITH FUSION ASSOCIATED SMALL TRANSMEMBRANE PROTEINS

#222
20240368138
2024-11-07

SELF DEGRADATION-TYPE CDK9 INHIBITOR PRODRUG AND LIPOSOME ENCAPSULATING SAME

#223
20240366745
2024-11-07

TROPICAL DISEASE VACCINES

#224
20240366740
2024-11-07

INTERLEUKIN-12 SELF-REPLICATING RNA AND METHODS

#225
20240366732
2024-11-07

MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A

#226
20240366527
2024-11-07

HONOKIOL LIPOSOME TRANSDERMAL GEL, PREPARATION METHOD AND USE THEREOF

#227
20240360072
2024-10-31

Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof

#228
20240358706
2024-10-31

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

#229
20240358639
2024-10-31

NANOPARTICLES FOR CANCER TREATMENT

#230
20240358635
2024-10-31

LONG CYCLE-LIFE WOUND LITHIUM-ION BATTERY CELLS HAVING METALLIZED FILM CURRENT COLLECTORS

#231
20240350621
2024-10-24

DOUBLE STRANDED MRNA VACCINES

#232
20240350411
2024-10-24

METHODS FOR PREPARING LIPOSOMAL FORMULATIONS

#233
20240350410
2024-10-24

FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF

#234
20240342307
2024-10-17

Liver Specific Delivery of Messenger RNA

#235
20240342206
2024-10-17

mRNAS FOR TREATMENT OR PROPHYLAXIS OF LIVER DISEASES

#236
20240342162
2024-10-17

Methods For Treating Pancreatic Cancer Using Combination Therapies

#237
20240335559
2024-10-10

CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF

#238
20240335383
2024-10-10

NANOPARTICULATE FORMULATION

#239
20240327476
2024-10-03

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#240
20240325327
2024-10-03

METHOD FOR ATTENUATING NEUROINFLAMMATION, AMYLOIDOPATHY AND TAUOPATHY

#241
20240325308
2024-10-03

AMNIOTIC FLUID STABILIZED COMPOSITIONS AND METHODS FOR IN UTERO DELIVERY OF THERAPEUTIC AGENTS

#242
20240316212
2024-09-26

COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY

#243
20240307526
2024-09-19

COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS

#244
20240307319
2024-09-19

IONIZABLE LIPID MOLECULE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF LIPID NANOPARTICLE

#245
20240299301
2024-09-12

LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME

#246
20240293318
2024-09-05

CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS

#247
20240293317
2024-09-05

LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF

#248
20240285798
2024-08-29

TREATMENT OF PRIMARY CILIARY DYSKINESIA WITH SYNTHETIC MESSENGER RNA

#249
20240285754
2024-08-29

MRNA VACCINES ENCODING FLEXIBLE CORONAVIRUS SPIKE PROTEINS

#250
20240285530
2024-08-29

REDUCING HYDROPHOBIC DRUG ADSORPTION IN ECMO CIRCUITS

#251
20240269325
2024-08-15

Polynucleotide compositions, related formulations, and methods of use thereof

#252
20240261223
2024-08-08

MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS

#253
20240261222
2024-08-08

SYSTEMS AND METHODS FOR TARGETED BREAST CANCER THERAPIES

#254
20240252678
2024-08-01

SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS

#255
20240252436
2024-08-01

DUAL-TARGETING BIOMIMETIC LIPOSOME WITH ELEMENE (ELE) AND CABAZITAXEL (CTX), AND PREPARATION METHOD AND USE THEREOF

#256
20240252435
2024-08-01

Cationic lipid compound, composition containing same and use thereof

#257
20240252434
2024-08-01

LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID

#258
20240245618
2024-07-25

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

#259
20240245606
2024-07-25

SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE

#260
20240238404
2024-07-18

INFLUENZA VIRUS NUCLEIC ACID LIPID PARTICLE VACCINE

#261
20240238210
2024-07-18

POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS

#262
20240226275
2024-07-11

Compositions and methods of mRNA vaccines against novel coronavirus infection

#263
20240226090
2024-07-11

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan

#264
20240216278
2024-07-04

METHODS FOR PRODUCING NANOPARTICLE DISPERSIONS

#265
20240216277
2024-07-04

Liposome compositions comprising weak acid drugs and uses thereof

#266
20240216276
2024-07-04

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

#267
20240209068
2024-06-27

MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA

#268
20240207444
2024-06-27

LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PHENYLALANINE HYDROXYLASE AND USES THEREOF

#269
20240197759
2024-06-20

IMMUNE STIMULATING NANOPARTICLE COMPOSITION

#270
20240197633
2024-06-20

PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF

#271
20240189449
2024-06-13

LIPID NANOPARTICLES AND POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#272
20240189232
2024-06-13

PROTEOLIPID VESICLES FORMULATED WITH FUSION ASSOCIATED SMALL TRANSMEMBRANE PROTEINS

#273
20240189221
2024-06-13

METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE

#274
20240181062
2024-06-06

RED-SHIFTED PHOTOLIPIDS AND NANOPARTICLES FORMED FROM SAME

#275
20240180835
2024-06-06

Sterically stabilized carrier compositions for treating a mammal

#276
20240180834
2024-06-06

DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT

#277
20240175024
2024-05-30

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

#278
20240173431
2024-05-30

NANOTHERAPEUTICS FOR TREATMENT OF SARS-COV-2

#279
20240173374
2024-05-30

LIPOSOMAL FORMULATIONS OF BORONIC ACID CONTAINING ACTIVE AGENTS

#280
20240173321
2024-05-30

ALPHA POLYGLUTAMATED PEMETREXED AND USES THEREOF

#281
20240173258
2024-05-30

LIPOSOME COMPOSITIONS AND METHODS OF USE THEREOF

#282
20240173257
2024-05-30

Liposome formulations

#283
20240156733
2024-05-16

METHODS OF PREPARATION OF NOVEL PAN TLR ANTAGONISTIC LIPOSOMAL-LNP FORMULATIONS AND USES THEREOF

#284
20240148794
2024-05-09

LNP COMPOSITIONS COMPRISING PAYLOADS FOR IN VIVO THERAPY

#285
20240139113
2024-05-02

LIPID NANOPARTICLE WITH TARGET INTEGRIN FUNCTION AND USES THEREOF

#286
20240131193
2024-04-25

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

#287
20240131172
2024-04-25

USE OF HIGH MOLECULAR WEIGHT POLYETHYLENE GLYCOL COMPOSITIONS TO RESTORE THE EFFICACY OF PEGYLATED THERAPEUTIC COMPOSITIONS

#288
20240130969
2024-04-25

LIPID NANOPARTICLES AND METHODS OF USE THEREOF

#289
20240124388
2024-04-18

Compounds and compositions for intracellular delivery of therapeutic agents

#290
20240123087
2024-04-18

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

#291
20240123084
2024-04-18

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

#292
20240123035
2024-04-18

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#293
20240123007
2024-04-18

HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE THEREOF

#294
20240122854
2024-04-18

NOVEL CARBONYL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS

#295
20240122853
2024-04-18

COMPOSITION FOR PENETRATING BLOOD-BRAIN BARRIER, CONTAINING SONOSENSITIVE LIPOSOMES AS ACTIVE INGREDIENTS

#296
20240115636
2024-04-11

ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE

#297
20240115136
2024-04-11

Multiple CEST contrast imaging of nose-to-brain drug delivery using CT-contrast agent-loaded liposomes

#298
20240102020
2024-03-28

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

#299
20240099975
2024-03-28

ANTI-TUMOR AGENT

#300
20240099974
2024-03-28

TREATMENT AGENT